Dehydration of Stenfilcon A Contact Lenses Versus Delefilcon A Contact Lenses

NCT ID: NCT02366923

Last Updated: 2020-07-29

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

28 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-04-30

Study Completion Date

2015-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study will explore in vivo lens dehydration rates across a 12hr wear period for the study lenses.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study will explore in vivo lens dehydration rates across a 12hr wear period for the study lenses. The primary outcome variable for this study is the loss in lens weight over the day, which will indicate the amount of dehydration that has occured.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myopia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

stenfilcon A

Each subject will be randomized to wear the test lens in one eye and control lens in the other eye (contra lateral design).

Group Type EXPERIMENTAL

stenfilcon A

Intervention Type DEVICE

Each subject randomized to wear either the test or control in either the left of right eye.

delefilcon A

Intervention Type DEVICE

Each subject randomized to wear either the test or control in either the left of right eye.

delefilcon A

Each subject will be randomized to wear the test lens in one eye and control lens in the other eye (contra lateral design).

Group Type ACTIVE_COMPARATOR

stenfilcon A

Intervention Type DEVICE

Each subject randomized to wear either the test or control in either the left of right eye.

delefilcon A

Intervention Type DEVICE

Each subject randomized to wear either the test or control in either the left of right eye.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

stenfilcon A

Each subject randomized to wear either the test or control in either the left of right eye.

Intervention Type DEVICE

delefilcon A

Each subject randomized to wear either the test or control in either the left of right eye.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Is at least 17 years of age and has full legal capacity to volunteer;
2. Has read and signed an information consent letter;
3. Is willing and able to follow instructions and maintain the appointment schedule;
4. Is a current wearer of soft contact lenses and has worn them (any brand) more than 3 months.
5. Is able to wear lenses for at least 12 hours a day.

Exclusion Criteria

1. Is participating in any concurrent clinical study;
2. Has any known active\* ocular disease and/or infection;
3. Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
4. Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable;
5. Has known sensitivity to the diagnostic pharmaceuticals to be used in the study;
6. Has undergone refractive error surgery;

* \*For the purposes of this study, active ocular disease is defined as infection or inflammation which requires therapeutic treatment. Mild (i.e. not considered clinically relevant) lid abnormalities (blepharitis, meibomian gland dysfunction, papillae), corneal and conjunctival staining and dry eye are not considered active ocular disease. Neovascularization and corneal scars are the result of previous hypoxia, infection or inflammation and are therefore not active.
Minimum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

CooperVision, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lydon Jones, PhD FC

Role: PRINCIPAL_INVESTIGATOR

Director, Centre for Contact Lens Research

Farah Panjwani, BSc RAQ

Role: PRINCIPAL_INVESTIGATOR

Univerisy of Waterloo

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Waterloo School of Optometry

Waterloo, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EX-MKTG-56

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.